Company / Revenue
Whitehawk Therapeutics, Inc. Revenue History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$26.0M
FY2025
5-year range
$14.0M / $26.0M
FY2021-FY2025
Trend
+6.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has fluctuated over the past 8 years, ranging from $0 in FY2020 to $26M in FY2025.
Based on SEC 10-K filings.
$26M in FY2025 with a 3-year CAGR of +22.9%.
Improved from $14M to $26M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- +22.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +22.9%, indicating consistent growth.
- In FY2025, revenue increased 6.7% year-over-year.
- Lowest revenue in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $26.0M | +6.7% |
| FY2024 | $24.4M | +74.0% |
| FY2023 | $14.0M | +0.0% |
| FY2022 | $14.0M | -4.0% |
| FY2021 | $14.6M | - |
| FY2020 | $0 | -100.0% |
| FY2019 | $20.2M | +1411.8% |
| FY2018 | $1.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026